This review demonstrates m6A methylation's regulatory roles in male reproductive disorders and urological cancers, highlighting its therapeutic potential.
Key Points
N6-methyladenosine methylation affects male reproductive health, including infertility and hormone functions.
The review summarizes m6A's impact on processes like steroidogenesis and metabolic reprogramming in urological cancers.
m6A regulation by proteins influences somatic cell functions and therapeutic strategies for reproductive disorders.
Targeting m6A could offer new solutions for addressing male reproductive challenges and urological malignancies.